BioHealth Innovation, Inc. (BHI), a new regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today its selection of Todd Chappell as the first Entrepreneur-in-Residence (EIR) for BHI at the National Institutes of Health (NIH) Office of Technology Transfer (OTT). Mr. Chappell, a venture capital-backed entrepreneurial leader and inventor with more than ten years of experience in molecular biology research, drug development and life sciences business strategy, will help support the development of new start-up companies based upon OTT technology license agreements.
“Todd’s proven track record in attracting funding and developing successful businesses around research products makes him the ideal candidate to serve as our first Entrepreneur-in-Residence,” said Richard Bendis, BHI Interim CEO. “Todd’s appointment underscores the goal of the BHI-NIH partnership intermediary agreement that we announced earlier this month: to advance human health while growing jobs in Central Maryland through the formation of new companies.”
To read the full, original article click on this link: BioHealth Innovation, Inc. Names Todd Chappell Its First Entrepreneur-in-Residence at National Institutes of Health Office of Technology Transfer
